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Abstract. The 83-kilodalton (kD) apical membrane antigen of Plasinodiuin falciparum 
(PF83/AMA- 1) is a potential asexual blood stage vaccine component. This antigen has 
been expressed as a full-length, nonfusion, recombinant baculovirus protein (PF83-7G8- 1) 
using the authentic predicted signal peptide for appropriate postsynthetic routing. When 
purified by a novel high-performance, ion exchange chromatography (HPIEC) method, 
PF83-7G8-1 induced polyclonal antibodies in rats that immunoprecipitated both 83- and 
66-kD forms of PF83/AMA-1 from 35S-methionine metabolically labeled parasite extracts. 
Using HPEC-purified PF83-7G8-1 in combination with a rat monoclonal antibody against 
the highly conserved carboxy-terminal (CT) region of PF83/AMA-1, we developed a CT- 
capture-enzyme-linked immunosorbent assay to measure naturally acquired responses 
against the entire PF83/AMA-l molecule. Analysis of populations from villages in Guinea- 
Bissau and in an area of high malarial transmission in Senegal demonstrated a very high 
prevalence (94100%) of naturally acquired serum IgG responses to PF83/AMA-I. Anal- 
ysis of these natural responses showed that PF83/AMA-l may be a well-recognized asexual 
parasite antigen. A statistically significant age-related change in antibody levels to PF83l 
AMA-1 was observed in Guinea-Bissau. No such correlation was observed in the Sene- 
galese population, although an age-related antibody response was seen for total parasite 
antigen. No significant correlation was observed between PF83/AMA- I responses and the 
parameters of parasite load and malaria-related fever. 
Current efforts to develop a vaccine against 
Plasniodiuriz falciparuiiz target all vertebrate life 
cycle stages of the parasite for immunointerven- 
tion. Within the erythrocytic cycle, which is re- 
sponsible for clinical disease, several asexual 
blood stage proteins have been characterized and 
are,putative components for inclusion in a ma- 
laria vaccine.'-' The P. falciparuin merozoite 83- 
kilodalton (kD) apical membrane antigen (PF83/ 
AMA-1) (Thomas AW, unpublished data)'V2 is 
one of these molecules. A strong basis for the 
vaccine candidacy of PF83lAMA-1 is the result 
of work by Deans and others,s who identified a 
66-kD P. kizowlesi late-stage apical protein (sub- 
sequently called PK66), which was the target of 
inhibitory monoclonal antibodies (MAbs) in 
vitro. These antibodies retained their activity as 
Fab fragments and appeared to inhibit parasite 
development in  a manner independent of schiz- 
ont maturation: suggesting a functional role for 
PK66 in erythrocyte invasion. Strong protective 
responses were induced in rhesus monkeys by 
immunization with PK66 in combination with 
exposure to P. krzo~les i . '~  The PF83/AMA-I an- 
tigen is an 83-kD analog of PK66 (Thomas AW, 
unpublished data).', Molecular analysis of 
PF83/AMA-1 and PK66/AMA-1 has shown that 
the two species are biologically conserved with 
regard to late-stage synthesis in mature schizonts 
and differential subcellular localization within 
schizonts and free merozoites.Il In addition, ini- 
tial work suggests that polymorphism in PF83/ 
AMA- 1 is limited.I2 Serum antibodies acquired 
during the course of naturally occumng infec- 
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. tion have been reported for other malaria vac- 
cine candidate  antigen^;'^'^ however, the prev- 
alence of naturally acquired antibodies against 
p~831AMA-1 has not been previously reported. 
Here, we describe the development and charac- 
terization of a eukaryotic baculovirus, full- 
length PF83/AMA-1 recombinant molecule 
(pF83-7G8-1), a carboxy-terminal-capture- 
enzyme-linked immunosorbent assay (CT-cap- 
ture-ELISA) using recombinant PF83-7G8- 1, 
and analysis of naturally acquired serum anti- 
bodies against PF83IAMA-I in Guinea-Bissau, 
an area of moderate endemicity, and in Senegal, 
an area holoendemic for P. falciparunz. 
MATERIALS AND METHODS 
Parasites. Plasrnodiurn falciparurn strain 7G8 
(Brazilian isolate cloned at the Walter Reed 
Army Institute of Research, Washington, DC) 
and a cloned line of P. fulciparunz NF54 named 
CVD-1 were maintained as previously de- 
scribed.*6.17 The schizonts of CVD-1 were ma- 
tured in culture in the presence of chymostatin 
and leupeptin to arrest merozoite release.'* Pel- 
leted schizonts were snap-frozen and stored in 
aliquots of 1 X lo8 at -180°C. Schizont pellets 
were rapidly thawed and extracted by sonication 
"in extraction buffer without detergent (1 X los/ 
m1) , I9  microfuged, and filtered (Millex-GV 0.22 
pM, Millipore, Bedford, MA). The parasite an- , tigen preparation was maintained in aliquots at 
-80°C. 
Recombinant baculovirus protein expres- 
sion and purification. Full-length PF83lAMA- 
1 (with putative signal peptide) of the 7G8 
strainI2 was amplified by the polymerase chain 
reaction using oligonucleotides that incorporated 
extreme NIze I sites. This product was cloned 
into the Nhe I site of the pJV (NIze I) baculovirus 
expression vectorz0 and sequenced. A single al- 
teration from the published sequence was noted 
at basepair 856 from A to G, resulting in an 
amino acid change from asparagine (N) to as- 
partic acid (D). Transfection in Spudoptera fru- 
$iperda 9 (Sf9) cells and cloning by plaque as- 
say were as described by Vialard and others.*O 
Conditions for growth and maintenance of Sf9 
cells and expression of PF83lAMA-1 protein by 
the recombinant virus were essentially according 
to Summers and Smith21 in TClOO insect cell 
medium (Gibco BRL, Gaithersburg, MD) sup- 
plemented with 10% fetal calf serum. For anal- _. 
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ysis of glycosylation of PF83lAMA-I, tunica- 
mycin (Sigma, St. Louis, MO), a specific 
inhibitor of asparagine-linked glycosylation,2? 
was incorporated into the expression protocol at 
a concentration of 5 pg/ml 1 hr after infection.23 
Full-length recombinant PF83-7G8- 1 was puri- 
fied as described.Ig Essentially, the purification 
method used an approach to high-performance 
ion-exchange chromatography (HPIEC) in 
which elution conditions were not only defined 
by charge, but also by hydrophobicity. The 
HPIEC purification of whole recombinant PF83- 
7G8-1 protein from Sf9 cell extracts involved 
two successive elutions with sodium chloride 
gradients that differed only in the concentration 
of the no%onic detergent polyoxyethylenealky- 
lether C,,E, (Kwant-Hoog Vacolie Recycling 
and Synthesis, Bedum, The Netherlands) present 
in the second gradient. This second elution pro- 
vided a pooled fraction that was composed of 2- 
9% recombinant PF83-7G8-1 as determined by 
scanning laser densitometry. The CT-capture- 
ELISA and LOUVAIN/M (LOU&¡) rat (Cath- 
olic University of Louvain, Louvain, Belgium) 
immunizations used HPIEC-purified recombi- 
nant PF83-7G8-1 protein. 
Antibodies and human sera. The PF83l 
AMA-1 reactive rat MAb 28G2dcl recognizes a 
highly conserved CT region, rat MAb 58F8dcl 
recognizes an amino-terminal (NT) region, and 
rat MAb 19H8dcl recognizes the merozoite sur- 
face protein-1 (MSP-1).I1 Antiserum was pre- 
pared against PF83-7G8-1 by multiple immuni- 
zation of 8-12-week-old, male, L O U M  rats at 
two-week intervals subcutaneously with HPEC- 
purified recombinant PF83-7G8- 1 in Freund's 
complete and incomplete adjuvants.24 Human 
sera were obtained from two different geograph- 
ic areas: one of moderate P. falciparunz endem- 
icity, Cumura, Guinea-Bissau, and a holoendem- 
ic areahillage, Dielmo, Senegal, in which 
transmission levels, when compared with other 
areas of westcentral Senegal, are unusually high 
as the result of the presence of a small perma- 
nent river.25 The samples available from Guinea- 
Bissau collected during September 1991 were 
from 50 children 2-9 years of age. The samples 
from Senegal, which were collected during June 
and the beginning of July 1990 and 1991 (the 
beginning of the rainy season), were from 199 
villagers between 2 and 86 years old; 51 villag- 
ers were 2-9 years of age.25 Twenty-two percent 
(Guinea-Bissau) and 92% (Senegal) of the 2-9- 
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year old children and 65% (Senegal) of the over- 
all population were positive for current P. faz- 
ciparum infection as judged by thick blood 
films. Some individuals were also positive for P. 
ovale and/or P. malariae. The Dielmo popula- 
tion is the subject of an ongoing, long-term 
study initiated in 1990, for which the current 
data base enables the analysis of a wide range 
of malariometric parameters, and for which fu- 
ture comparisons will be even more informative 
as further data (such as human leukocyte antigen 
typing) becomes available.= The Guinea-Bissau 
study population is also part of an ongoing study 
that will permit us to address long-term issues 
more effectively in the future. 
Immunoblotting. Recombinant expression of 
PF83-7G8-1 protein was analyzed by 10% so- 
dium dodecyl sulfate-polyacrylamide gel relec- 
trophoresis (SDS-PAGE) essentially as previ- 
ously described.26 Gels were electroblotted onto 
nitrocellulose and probed with MAbs 28G2dc1, 
58F8dc1, and 19H8dc1. The migration of pres- 
tained molecular mass markers (Amersham In- 
ternational, Hertogenbosch, The Netherlands) is 
noted alongside all figures. Blotted tracks con- 
tained the equivalent of 1 X lo5 cells per track. 
Tracks were probed with monoclonal antibodies 
(5 pg/ml) for 1 hr at 20°C. All immunoblots 
were developed using alkaline phosphatase-con- 
jugated reagents (Pierce, Oud Beijerland, The 
Netherlands). 
Metabolic labeling of parasites. Synchro- 
nous schizont populations were prepared by 
, double sorbitol treatment of asynchronous cul- 
tured parasites at time O and 32 hr later, thereby 
producing a ring population that had an age dis- 
tribution from O to 4 hr. After parasite matura- 
tion, schizonts were purified'* with Nycodenz 
(Nycomed, Oslo, Norway) and cultured at a 
concentration of 5 X lo7 schizonts/ml. Schizonts 
were then metabolically pulse-labeled with 100 
pCi/ml of ,%-methionine (Amersham Interna- 
tional) in methionine-free medium. After 2 hr, 
metabolically labeled schizonts were rapidly 
pelleted, washed, snap-frozen, and stored at 
- 80°C. 
Preparation and analysis of ,?3-methio- 
nine-labeled parasite material. Aliquots of 5 
X lo7 schizonts were s0lubilized,2~ precipitated 
with trichloroacetic acid (TCA), and counted by 
liquid scintillation. Samples containing equal 
TCA-precipitable counts per minute (cpm) were 
immunoabsorbed with human or pooled immune 
rat IgG coupled to protein G agarose 
(GammaBind Plus; Genex Corp., Gaithersburg, 
MD) or MAb coupled to cyanogen bromide-ac- 
tivated Q-Sepharose CL 4BI9 and washed as pre- 
viously described.27 Antigens were analyzed by 
SDS-PAGE and fluorography essentially as pre- 
viously described.26 
Enzyme-linked immunosorbent assay: CT- 
capture-ELISA and total parasite-ELISA. 
Sera from Guinea-Bissau were heat-inactivated 
at 56°C for 30 min. Samples from Senegal were 
not heat-inactivated because serum samples 
were limited. No difference in ELISA indices 
were observed between the two methods of se- 
rum preparation. High protein-binding, 96-well, 
flat-bottomed microtiter ELISA plates (Greiner, 
Labortechnik, Solingen, Germany) were coated 
with 1) 50 pVwell of MAb 28G2dcl (16 pg/ml) 
in phosphate-buffered saline (PBS, pH 7.4) plus 
0.02% NaN, for the CT-capture-ELISA, or 2) 50 
pl/well of a 1: 1,000 dilution of parasite sonicate 
in the same buffer, and incubated overnight at 
4°C. Coated plates were washed five times with 
Tris-buffered saline, pH 7.4, plus 0.05% Tween 
20 (TBSEween 20), then blocked with 200 pl/ 
well of 3% bovine serum albumin (BSA) in 
PBS, pH 7.4, for 60 min at 37°C. The blocking 
buffer was discarded and the ELISA plates were 
flicked dry. 
For the CT-capture-ELISA, 50 pl/well of 
pooled HPIEC-purified PF83-7G8-1 (75 ng/ml) 
in PBS, pH 8.0, plus 0.5% BSA was added to 
the plates and incubated for 90 min at 37°C. The 
plates were then washed five times with TBSI 
Tween 20. Sera diluted 1:200 in PBS, pH 8.0, 
plus 0.5% BSA were added in duplicate (50 p1/ 
well) and incubated for 90 min at 37°C. The 
plates were then washed five times with TBS/ 
Tween 20. A total of 50 pVwell of alkaline phos- 
phatase-labeled goat anti-human IgG (H & L) 
(Pierce) diluted 1:2,500 in PBS, pH 8.0, plus 
0.5% BSA was added and incubated for 60 min 
at 37°C. The plates were then washed five times 
with TBS/Tween 20 prior to the addition of 50 
pl/well of p-nitrophenyl phosphate (1 mg/mi) in 
100 mM diethanolamine (pH 9.8). The reaction 
times for the development of the CT-capture- 
ELISA and total parasite-ELISA were 25 and 60 
min, respectively. The optical density at 405 nm 
(OD,,5) was determined using a Titertek Multis- 
can PLUS MKII apparatus (ICN Biochemicals 
BV, Zoetermeer, The Netherlands). Bound IgG 
is reported as a ratio essentially as determined 
î 
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by Fidock and others28 and as follows: a panel 
of 40 randomly selected unexposed European 
sera from persons with no history of malaria ex- 
posure were used to determine a geometric mean 
for the CT-capture-ELISA background. Five 
nonimmune sera that represented the geometric 
mean were then selected and used as negative 
controls on each ELISA plate in the CT-capture- 
and total parasite-ELISAs. Sera from two indi- 
viduals living in a holoendemic area of Cote 
d'Ivoire29 were also included on each plate as 
positive controls. Individual ELISA index (EI) 
values were determined by dividing the arith- 
metic mean of experimental values by the geo- 
metric mean plus two times the standard devia- 
tion (SD) of the five negative control samples. 
Analysis of both populations using the geomet- 
ric mean plus three times the SD of the five neg- 
ative control samples did not change the preva- 
lence of positive responses. Individuals with an 
EI less than one were considered nonresponders. 
Responders in the CT-capture-ELISA and total 
parasite-ELISA had OD,,, readings at least 15% 
and 9.2%, respectively, above the geometric 
mean of the ODjas of the negative controls. The 
coefficient of variation (day to day experimental 
variation) of the nonimmune controls, as de- 
scribed by Venkatesan and Wakelin,3a was 9.5% 
ä n d  16% for the CT-capture- and total parasite- 
ELISAs, respectively. 
RESULTS 
The PFS3-7GS-1 baculovirus recombinant 
protein. Full-length PF83lAMA- 1 has been ex- 
pressed as a recombinant baculovirus protein 
(PF83-7G8-1). The recombinant protein is ini- 
tially expressed as a correctly oriented 
transmembrane protein in Sf9 cells because cell 
surface immunofluorescence with fresh, unfixed 
infected Sf9 cells is positive with the NT MAb 
(58F8dcl) but not with the CT MAb (28G2dcl). 
The same preparations after drying and metha- 
nol fixation are recognized by both NT and CT 
MAbs. Analysis of PF83-7G8-1 expression in 
sf9, Sf21, and High Five@ (BTI-TN-5B1-4 de- 
rived from Triclzoplusia ni egg cell homoge- 
nates; Invitrogen, San Diego, CA) cells dem- 
onstrated that PF83-7G8-1 is equally expressed 
in Sf9 and Sf21 cells: however, expression in 
High Five cells is reduced. Recombinant PF83- 
7G8-1 migrates under denaturation conditions as 
a 90-kD protein (Figure 1). To examine the pos- 
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FIGURE 1. Expression and N-linked glycosylation 
of the 83-kilodalton (kD) apical membrane antigen of 
Plus~rtodiunz falciparurn expressed as a full-length, 
nonfusion, recombinant baculovirus protein (PF83- 
7G8-1) The PF83-7GS-I-infected Sf9 cells were cul- 
tured for approximately 48 hr without (lanes l) or with 
(lanes 2) tunicamycin, separated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis, and im- 
munoblotted .with monoclonal antibody (MAb) 
19H8dcl (A) or pooled MAbs 28G2dcl and 5SF8dcl 
(W. 
sibility of N-linked glycosylation, PF83-7G8- 1- 
infected Sf9 cells were cultured with and with- 
out tunicamycin. In the presence of tunicamycin, 
PF83-7G8-1 is expressed predominantly as an 
83-kD protein similar to that of the native par- 
asite protein (Figure 1). Maximum protein pro- 
duction for PF83-7G8-1 and the optimal time of 
harvest was between 72 and 96 hr postinocula- 
tion. Pooled sera from rats that were immunized 
with HPIEC-purified PF83-7G8- 1 immunopre- 
cipitated both 83- and 66-kD forms of native 
PF83/AMA-l (Figure 2) and reacted with native 
PF83lAMA- 1 by indirect immunofluorescent an- 
tibody assay, giving the expected punctate flu- 
orescence pattern in mature schizonts. 
Carboxyl-terminal-capture-ELISA. A cap- 
ture-ELISA was developed to measure antibody 
responses against PF83lAMA-1 using the CT 
734 
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FIGURE 2. Immunoabsorption of 35S-methionine 
metabolically labeled Plasmodium falciparum mature 
schizonts by pooled immune rat sera against high-per- 
formance, ion-exchange chromatography-enhanced ß- 
galactosidase (A) and the 83-kilodaIton (m) apical 
membrane antigen of P. falcipanan expressed as a 
full-length, nonfusion, recombinant baculovirus pro- 
tein Spodopieru fmgiperda 9 cell extract (B). Samples 
containing 5 X lo5 counts per minute were analyzed 
by sodium dodecyl sulfate-polyacrylamide gel electro- 
phoresis and fluorography. 
MAb (2SG2dc1) to capture HPIEC-purified 
PFS3-7G8-1. The ELISA conditions were exten- 
sively tested to ensure that the measured human 
antibody responses were specific for PFS3-7GS- 
1. This included comparison with a CT-capture- 
ELISA using the analogous fraction from 
HPIEC-fractionated protein extracts of Sf9 cells 
that had been infected with the wild-type bacu- 
lovirus. In this assay, a randomly selected range 
of normal and hyperendemic sera gave OD,, 
values that were equivalent to those of the nor- 
mal serum samples when tested against PFS3- 
7G8-1. Responses to insect cell contaminants or 
rat MAbs did not therefore interfere with the 
readout of the assay. 
Serum antibodies to PFS3/AMA-1. Serum 
antibody levels against P. falciparum PFS31 
AMA-1 were measured by CT-capture-ELISA in 
50 children, ages 2-9 years, from Cumura, 
Guinea-Bissau, an area of moderate endemicity, 
and in 199 villagers, ages 2-86 years, from Diel- 
mo, Senegal, a holoendemic area. An initial 
analysis within the Dielmo population was un- 
dertaken to assess the relationship between end- 
point titration and single dilution OD,, mea- 
surements in this ELISA. A close agreement 
between the two approaches was observed (Fig- 
ure 3), and therefore all subsequent analyses 
used the simpler, single dilution measurement. 
All individuals in the Guinea-Bissau study and 
94% of the Dielmo villagers (with a distribution 
independent of age) had detectable naturally ac- 
quired antibodies (IgG) to PF83/AMA-1. A sta- 
tistically significant correlation between serum 
IgG levels specific for PF83lAMA-1 and age 
was observed in the 2-9-year-old population 
from Guinea-Bissau (P  < 0.005, Spearman 
rank-order correlation coefficient = 0.43) Fur- 
thermore, a statistically significant correlation 
was observed between serum IgG levels and age 
when the children were put into groups 2-4 and 5 
5-9 years of age (P < 0.001, by Wilcoxon sum 
rank test) (Figure 4). No similar correlation was 
observed within the age period examined for re- 
sponses to total parasite antigen (Figure 4). No 
age-related response to PFS3lAMA-1 was evi- 
dent in the Dielmo population, although in con- 
trast, within the same population, age-related re- 
sponses to total parasite material were observed 
(P  < 0.001, Spearman rank-order correlation co- 
efficient = 0.38) (Figure 5). No statistically sig- 
nificant differences by sex in terms of humoral 
immune responses were observed in either pop- 
ulation. No correlation could be determined be- 
tween individual EIS and l )  PFS3/AMA-l im- 
mune responses and the development of fever or 
clinical malaria within Dielmo villagers from 
June to September 1990, 2) the presence of 
mixed infections within the Dielmo villagers, or 
3) the parasite load evident on Giemsa-stained 
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FIGLIRE 3. Correlation between enzyme-linked im- 
munosorbent assay (ELISA) indices and endpoint titers 
from 40 random sera samples from Dielmo, Senegal. 
The solid line represents linear regression through the 
data; the dashed lines represent 95% confidence inter- 
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FIGURE 4. Results of carboxy-terminal (CT)-cap- 
ture- and total parasite enzyme-linked immunosorbent 
assays (ELISAs) of serum samples from Guinea-Bis- 
sau. The CT-capture-ELISA results show a relationshia 
between antibody levels (IgG) against the 83-kilodaî- 
ton apical membrane antigen of plus rizo di un^ .folcipu- 
rum (PF83lAMA-1) and age. m = arithmetic mean and 
blFod films prepared at the time blood speci- 
mens were collected in either population. To 
compare responses with time, sera from approx- 
imately 10% of the Dielmo population were also 
assessed one year later (1991). Individual serum 
IgG levels specific for PF83/AMA-I did not sig- 
nificantly differ between the 1990 samples and 
those taken during the equivalent period of 1991 
- (P 0.59, by Wilcoxon matched-pairs signed 
ranks test). This comparison was made on a 
small number of individuals 2-4 (n = 4) and 5- 
9 (n = 2) years of age. 
Relationship between the EI and the rec- 
ognition of native PFS3lAMA-I. Sera from two 
inhabitants from Guinea-Bissau, three and seven 
Years of age (with EIS for PF83/AMA-1 of 1.30 
and 2.28, respectively), were used to analyze hu- 
man immune recognition of native PF831AMA- 
1. AS expected, a restricted range of parasite 
proteins was preferentially recognized by the 
Sera (Figure 6). Although PF83/AMA-1 is a pro- 
tein synthesized in such relatively small amounts 
that it is not, even during its period of maximal 
expression, discernible on fluorographs within 
_- the total synthetic activity, it was notable that 
SEM ELISA indices for responses to PF83lAMA-1: 0 
= arithmetic mean and SEM ELISA indices for total 
parasite antigen. Age group sizes (n) for those with 
PF83/AMA-1 and those with total parasite antigen, re- 
spectively, were 2 1  years of age, n = 16 and n = 15: 
5-9 years of age, n = 34 and n = 34. Sera were diluted 
1:200. One sample (from an individual in the 2-4- 
years-old age group) contained an insufficient quantity 
of serum to test against total parasite antigen. Exclud- 
ing this sample, all individuals were seropositive for 
both total parasite antigen and PF83/AMA-I. The as- 
sociation between the ELISA index for PF83lAMA-1 
and age are statistically significant (P  < 0.001, by the 
Wilcoxon sum rank test). 
and 66 kD. These bands were specifically re- 
moved by PF83lAMA- 1 immunodepletion (Fig- 
ure 6. C1 and C2). In contrast. immunoprecipi- 
tation with an equivalent amount of serum from 
the three-year old with a low EI showed a 
marked reduction in the recognition of total par- 
asite antigens and immunoprecipitation of PF83/ 
AMA-1 was undetectable. Similar results were 
obtained for another pair of serum samples with 
low and high EIS. This quantitatively minor par- 
asite protein was therefore, in comparison with 
total parasite proteins, strongly recognized in the 
_ _  r ._- - -  ~ -- 
_ _  - -  
_ _  - 
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FIGURE 5. Results of carboxy-terminal-capture- 
and total parasite enzyme-linked immunosorbent as- 
says (ELISAs) of serum samples from Dielmo, Sene- 
gal. The ELISA results show relationships between 
naturally acquired antibody levels (IgG) against the 
83-kilodalton apical membrane antigen of Plusmodium 
fulciparum (PF83/AMA- I ) and total parasite antigen 
and age. = arithmetic mean and SEM ELISA indices 
for responses to PF83/AMA-1; O = arithmetic mean 
and SEM ELISA indices for total parasite antigen. Age 
groupings are as follows. in accordance with Trape and 
others.2s Age group sizes (n) for those with PF83/ 
AMA-1 and those with total parasite antigen, respec- 
tively, were 2 4  years of age, n = 20 and n = 5; 5-9 
years of age, n = 32 and n = 9; 10-14 years of age, 
n = 24 and n = 14; 15-19 years of age, n = 22 and 
n = 11; 20-39 years of age, n = 56 and n = 12; 40- 
59 years of age, n = 28 and n = 14; 60 or more years 
of age. n = 17 and n = 14. Sera were diluted 1:200. 
DISCUSSION 
We have used a new CT-capture-ELISA to 
show that PF83/AMA-1, a quantitatively minor, 
transiently expressed component of the mature 
schizont and merozoite, is highly recognized in 
humoral responses of all age groups in two dif- 
ferent endemic areas of Africa. The recombinant 
PF83/AMA-i used in this assay was a full- 
length molecule expressed in a baculovirus sys- 
tem in which the authentic predicted signal pep- 
tide was used to facilitate entry into an 
appropriate postsynthetic routing pathway. The 
transmembrane localization of the molecule after 
Sf9 expression suggests that this is indeed the 
case. Protection induced in vitro by PK661AMA- 
1 appeared to be dependent upon a conforma- 
kD 
200 
97.4 
69 
46 
30 c i .  
-...-a- 
1 2 1 2 1 2  
A 6  C D  
kD 
- 83 
-66  . 
FIGURE 6. Analysis of the recognition of native 83- 
liilodalton (kD) apical membrane antigen of Plusmo- 
diuni fulcipurum (PF83/Ah1.4-1) by human sera from 
Guinea-Bissau. Extracts of "S-methionine metaboli- 
cally labeled schizonts were iinmunoabsorbed with hu- 
man IgG coupled to protein Cilagarose. Semm samples 
were from a nonimmune adult male (A); a three-year- 
old girl, enzyme-linked immunosorbent assay (ELISA) 
index (EI) = 1.30 (B); a seven-year-old boy, E1 = 2.28 
(C); and a positive control (immunoabsorption of 
PF83/AMA- 1 by anti-PF83/AMA- 1 monoclonal anti- 
bodies (D). Lanes 1 and 2 represent parasite extracts 
immunodepleted of or containing PF83/AMA-l. re- 
spectively. Immunoprecipitates of metabolically la- 
beled parasite extracts that contained 1.5 X 1oh counts 
per minute (cpm) (A-C) and 6 X 106 cpm (D) were 
analyzed by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (7.5% polyacrylamide gel) and 
fl uorography . 
tional epitope" and PF83IAMA-1 contains cys- 
teine and proline residues that are almost all 
positionally conserved with PK66/XMA- 1. Cor- 
rect targeting of recombinant molecules has 
been shown to be necessary for the authentic 
expression of large fragments of other malarial 
proteins to form correct disulfide cross-ijnks,3' 
and this is expected to be critical in the produc- 
tion of authentic PF831AMA- I .  Under reducing 
conditions, recombinant PF83-7G8- 1 has an ap- 
parent molecular mass that is 7 kD greater tharl 
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fiat of the native protein, which is attributable 
to aberrant (non-native) N-linked glycosylation. 
It is not yet clear whether N-linked glycosylation 
affects correct folding of this molecule or how 
it might alter potential recognition of immuno- 
logical  determinant^.^^ Limited N-linked glyco- 
sylation of a baculovirus C-terniinal product of 
MSP-1 did not interfere with its recognition by 
inhibitory MAbs that recognize conformational 
epi t~pes.~ '  
The analysis of naturally acquired serum IgG 
responses by CT-capture-ELISA in areas of 
moderate and holoendemic P. fakiparum dem- 
onstrated a high prevalence of serum IgG re- 
sponses against PF83lAMA-1. Of particular in- 
terest, this included children 2-4 years of age. 
The limited reports to date regarding the prev- 
alence of acquired serum IgG responses in chil- 
dren 1-4 years of age to other parasite antigens 
has shown a fairly large variation in serum pos- 
itivity among exposed populations. For example, 
responses to the circumsporozoite protein CSP- 
1 could be measured in 10-53% of the chil- 
dren,14*15333 responses to MSP-1 in 70%,13.34 and 
responses to the ring-infected erythrocyte sur- 
face antigen (RESA) in 2040% of the children 
in two different hyperendemic villages of west- 
ern Kenya.I4 Although this variance may be at- 
tributable in part to differences in the constructs 
used (e.g., recombinant or synthetic peptide, 
fixed native material, etc.), and differences in the 
sensitivity of the methods for IgG detection 
used, it has been argued that the level of peren- 
nial transmission of P. falcipai-ilnt within differ- 
ent hyperendemic areas is a factor.I4 It is evident 
that for PF83lAMA-1 there is a very high prev- 
alence of naturally induced antibody responses 
to this antigen, even in the 2-4-year-old age 
groups of both the Dielmo and Cumura popu- 
lations. Different levels of exposure to the par- 
asite occur in the two populations (22% and 
92% point prevalence of the 2-4-year-old chil- 
dren in Guinea-Bissau and Senegal, respective- 
ly). However, in combination with the relatively 
high sensitivity of the CT-capture-ELISA (which 
is measuring responses to the entire PF83fAMA- 
1 molecule in a conformation that is likely to 
mimic its native state), the parasite prevalence 
in both populations is sufficient to generate very 
high PF83lAMA-1-specific responses. The lim- 
ited extent of the yearly variation observed in 
the level of PF83lAMA-I responses in Dielmo 
is also a likely consequence of the relatively per- 
sistent exposure to i n f e ~ t i o n . ' ~ . ~ ~  It is notable 
that in the above context, a recent study of the 
prevalence and level of responses to MSP-1 
showed no significant differences in serologic 
responses between individuals living in areas of 
low and high seasonal malaria transmission.35 
Here, the seasonal exposure to P. falcipaniiiz ob- 
served in Guinea-Bissau was evidently sufficient 
to induce responses to PF83lAMA-1. In contrast 
to measures of prevalence, however, there is a 
clear age-related increase in the level of re- 
sponse to PF83lAMA-1 observed in children 
from Guinea-Bissau, and an age-related change 
in response to total parasite antigen in Dielmo 
in the absence of such a phenomenon for PF83l 
AMA-1. 5he  changes observed in antibody lev- 
els to PF83lAMA-1 in Guinea-Bissau and total 
parasite antigen in Dielmo may be explained by 
an individual developing protective immunity 
with the occurrence of multiple parasite infec- 
tions. The absence of this phenomenon for 
PF83lAMA-1 in the children from Dielmo sug- 
gests that prior exposure to P. falciparrrm 
infection, particularly in the light of the very 
strong response to PFS3lAMA-1, has already 
been extensive enough to induce PF83lAMA-1 
responses similar to those of adults. 
Analysis of the 1990 samples from the Diel- 
mo population showed no correlation to 1) par- 
asite load at the time of sampling and 2) clinical 
malaria episodes between the time of sampling 
and September 1990: with individual EI against 
PF83lAMA-1. Thus, a protective component 
among the total naturally acquired PF83lAMA- 
1 antibodies as determined by the CT-capture 
ELISA could not be distinguished during the 
short-term follow-up period reported here. Al- 
though some protective trends within certain 
subpopulations were observed, they were not 
large enough to determine statistical signifi- 
cance, and a more extended follow-up will be 
required to draw definitive conclusions. We an- 
ticipate that, while the responses measured here 
against the full-length recombinant PF83/AMA- 
1 represent the overall recognition of the mole- 
cule within the population, protective responses 
will be determined by the specific recognition of 
defined regions or determinants, as has been 
shown for PK66/AMA-lZ7 and the C-terminus of 
MSP-1,36,37 or may be restricted to particular cy- 
tophilic isotypes.29 
Our initial analysis of the naturally acquired 
immune responses against PF83lAMA- 1 has 
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shown that both the 83- and 66-kD forms may 
be well-recognized in comparison with most 
other parasite proteins of the maturing schizont 
and merozoite. Naturally acquired antibodies 
against the rhoptry-associated protein-1 (RAP- 
1) also appear to be strongIy represented in the 
individual repertoire7 and are highly 
Whether this shared characteristic may be a 
more general feature of rhoptry and apical pro- 
teins of the merozoite is as yet unclear. 
The rapid response to PFSS/AMA-l requires 
more detailed investigation in younger popula- 
tions of Guinea-Bissau and Senegal. Further- 
more, the long-term analysis possible in both 
population groups will enable this study to be 
extended to a longitudinal investigation corre- 
lating PF83lAMA- 1 responses to malariometric 
parameters. The CT-capture-ELISA reported 
here will also be of more general valueuin the 
analysis of immune responses due to specific 
immunization with various constructs of PF831 
AMA- 1. 
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